Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Other financing activities (2017 - 2020)

Rocket Pharmaceuticals' Other financing activities history spans 2 years, with the latest figure at $139000.0 for Q2 2020.

  • For Q2 2020, Other financing activities changed N/A year-over-year to $139000.0; the TTM value through Mar 2021 reached $139000.0, up 41.84%, while the annual FY2020 figure was $237000.0, N/A changed from the prior year.
  • Other financing activities for Q2 2020 was $139000.0 at Rocket Pharmaceuticals, up from $98000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $139000.0 in Q2 2020 and bottomed at -$3.3 million in Q4 2018.